Figure 2
From: Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications
The mutation frequency and distribution of MEK1 in pancancer. (A) MEK1 mutation frequency in pancancer. (B) MEK1 mutation distribution belonging to different functional domains for all and the top 12 tumors.
